sitagliptin metformin axapharm 50 mg/1000 mg filmtabletten
axapharm ag - sitagliptinum, metformini hydrochloridum - filmtabletten - sitagliptini hydrochloridum 54.484 mg ut sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50.000 mg, metformini hydrochloridum 1000.000 mg, cellulosum microcristallinum, povidonum, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 1.3 mg. - orales antidiabetikum - synthetika
vildagliptin/metformin hcs 50 mg/1000 mg filmtabletten
hcs b.v.b.a. - metformin hydrochlorid; vildagliptin -
vildagliptin/metformin hcs 50 mg/850 mg filmtabletten
hcs b.v.b.a. - metformin hydrochlorid; vildagliptin -
vildagliptin/metformin stada 50 mg/1000 mg filmtabletten
stada arzneimittel gmbh - metformin hydrochlorid; vildagliptin -
vildagliptin/metformin stada 50 mg/850 mg filmtabletten
stada arzneimittel gmbh - metformin hydrochlorid; vildagliptin -
vildagliptin/metformin rivopharm 50 mg/1000 mg filmtabletten
holsten pharma gmbh - metformin hydrochlorid; vildagliptin -
vildagliptin/metformin rivopharm 50 mg/850 mg filmtabletten
holsten pharma gmbh - metformin hydrochlorid; vildagliptin -
galvus
novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).
xiliarx
novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).